Melanotan II MT2 Lyophilized Powder – HPLC Verified

Batch-Specific CoA with Named Analytical Methods — Every vial of Melanotan II (CAS 121062-08-6) ships with a certificate detailing HPLC, MS, and NMR methods used for that exact lot, enabling your QC lab to replicate results without guesswork.

Product Specification

Intended Use

Supplied as a raw material for research and manufacturing use. Not for human or veterinary use. Not a finished product.

What a Certificate Cannot Tell You Without the Method

Purity numbers without named analytical conditions are unverifiable claims, not data.

When a Certificate of Analysis states ">99% purity" but omits the HPLC column type, gradient program, or detection wavelength, the receiving laboratory has no basis to reproduce the result. In my experience coordinating analytical method alignment across珠三角 supplier labs and overseas QC teams, I have seen batches of Melanotan II MT2 Lyophilized Powder 5mg 10mg 15mg where the buyer’s lab used a different mobile phase composition and reported a purity discrepancy of several tenths of a percent — enough to trigger a month-long dispute. The root cause was never the peptide itself; it was the absence of method transparency on the original CoA. Melanotan II 121062-08-6 analytical verification purity HPLC data only becomes meaningful when every chromatographic parameter is locked in and documented. [NEED_CITE: HPLC method validation requirements per ICH guidelines]

Triple Verification Before Any Vial Ships

Each production lot undergoes three orthogonal analytical checks before release. HPLC establishes the purity profile against defined acceptance criteria. Mass spectrometry confirms the molecular ion matches the expected mass for Melanotan II (CAS 121062-08-6). NMR verifies structural integrity, detecting any sequence-level anomalies or unexpected modifications that HPLC alone would not flag.

Why Method Documentation Travels with the Shipment

The CoA included with every order names the specific chromatographic column, gradient conditions, flow rate, and detector settings used for that batch. This level of detail allows your QC laboratory to set up an identical method upon receipt rather than developing one from scratch. When Melanotan II 121062-08-6 analytical verification purity HPLC results need independent confirmation, having the original method summary eliminates the most common source of inter-laboratory variation. Retained samples from each lot are held at the manufacturing site so that any discrepancy can be investigated against the original material. [NEED_CITE: inter-laboratory variability in peptide purity assessment]

Reading the Specification Sheet Beyond the Headline Number

The stated purity of a lyophilized peptide reflects the area percent of the main peak under specific HPLC conditions — it does not account for water content, residual solvents, or counterion mass. For Melanotan II in lyophilized form, the actual peptide content by weight will differ from the chromatographic purity figure. Understanding this distinction prevents errors in preparing stock solutions for receptor binding assays or analytical method development. The water content, determined during batch release, directly affects how much powder must be weighed to achieve a target concentration. Storage at -20°C, sealed and protected from light, preserves the lyophilized matrix and slows any hydrolytic degradation pathways that could shift the impurity profile over the 24-month shelf life. Aliquoting reconstituted solutions into single-use volumes avoids the cumulative damage caused by repeated freeze-thaw cycles, which can promote aggregation and deamidation in synthetic peptides. The available 5mg, 10mg, and 15mg vial sizes support research-scale workflows where opening a large container repeatedly would introduce moisture and contamination risk.

The Hidden Cost of Misaligned Specifications

A CoA that lists a batch number not matching the physical vial label causes immediate rejection at receiving inspection, delaying projects by weeks while the supplier issues corrected documentation. When the analytical method is omitted or described vaguely, the buyer’s QC team must invest days optimizing conditions to match the supplier’s reported purity — time that compounds when multiple raw material lots await release. Temperature excursions during transit, if unrecorded, leave the receiving lab unable to determine whether an out-of-specification result stems from the material itself or from degraded product. For peptide raw materials intended as analytical reference standards, any uncertainty in the documentation chain invalidates downstream assay validation work. [NEED_CITE: cold chain packaging standards for temperature-sensitive materials]

Why Procurement Teams Source This Material Here

Every batch of Melanotan II (CAS 121062-08-6) is accompanied by a CoA that names HPLC, MS, and NMR as release methods — not generic claims but lot-specific analytical records. Custom synthesis to a buyer-supplied sequence and modification is available when catalogue grades do not meet a project’s requirements. Research quantities starting at 5mg and bulk scales are supplied from the same production line, ensuring consistency as a project moves from feasibility to scale-up. Temperature-controlled packing with transit temperature records accompanies every shipment so that cold chain integrity is verifiable on arrival. Import documentation — including certificate of origin, safety data sheet, and HS code 29371290 classification — is prepared per the destination country’s requirements before dispatch. Technical support on specification interpretation, method alignment, and storage handling is provided post-delivery to resolve any QC discrepancies efficiently.

Documentation & Traceability

• Batch-specific certificate of analysis stating HPLC, MS, and NMR methods used for this exact lot
• Analytical method summary with column type, gradient program, and detection parameters
• Mass spectrometry confirmation report matching molecular ion to expected Melanotan II mass
• Certificate of origin and HS code 29371290 documentation prepared per destination import requirements
• Safety data sheet covering handling, storage, and transport conditions for the lyophilized powder
• Retained sample record linking each vial to its original production batch for re-testing

Storage, Handling & Shipping

• Store Melanotan II lyophilized powder at -20°C in sealed, light-protected containers to maintain the 24-month shelf life
• Aliquot reconstituted solutions to avoid freeze-thaw cycles that degrade peptide integrity
• Reconstituted material remains stable approximately one month at 4°C or six months at -20°C
• Temperature-controlled packing with continuous transit logging accompanies each shipment
• Cold chain records provided upon delivery to verify unbroken temperature conditions throughout transit
• Import documentation including certificate of origin and safety data sheet prepared per destination requirements

How to Structure Your Inquiry

Provide the required vial size — 5mg, 10mg, or 15mg — along with the total quantity needed and your target analytical specifications. If your QC laboratory will re-test on receipt, share the HPLC method or column type you use so that method alignment can be confirmed before dispatch. Specify any destination-country import documentation requirements, including certificate of origin format or customs classification needs, to ensure paperwork is complete at the point of entry.

Frequently Asked Questions

Q: How is the batch-specific CoA linked to my order for full traceability?
A: Each vial label carries a unique batch number that corresponds directly to the CoA included in the shipment. The certificate records the production date, analytical results from HPLC, MS, and NMR testing, and the specific method parameters used. Retained samples from that same batch are held at the manufacturing site, allowing re-analysis if your QC laboratory reports a discrepancy upon receipt.

Q: Which analytical methods determine the reported purity?
A: Purity is established by HPLC using a defined column and gradient program, both documented on the batch CoA. Mass spectrometry confirms the molecular identity, and NMR verifies structural integrity. The method summary provided with the shipment includes sufficient detail — column specification, mobile phase composition, flow rate — for your laboratory to replicate the analysis independently.

Q: What is the protocol when our QC re-test results differ from the supplier CoA?
A: We first request your chromatographic conditions to identify any method differences. If alignment of parameters does not resolve the gap, we test the retained sample from the original batch under both our method and yours. This side-by-side comparison isolates whether the variance stems from method conditions or material change, and findings are documented in a shared report.

Q: How does the retained sample policy support re-testing?
A: A sealed sample from every production batch is stored under controlled conditions at the manufacturing site. If a dispute arises or additional testing is needed months after delivery, we can analyze this retained material and provide updated spectra. This ensures that verification is always performed against the exact lot that was shipped to you.

Q: What specification parameters are covered in the documentation package?
A: The CoA covers chromatographic purity by HPLC, mass confirmation by MS, structural verification by NMR, appearance, and water content. The method summary details all analytical conditions. Storage and handling sheets specify the -20°C requirement, light protection, and reconstitution guidance. Additional parameters can be added to the specification agreement before production if your project requires them.